699 results found

On April 8, 2021, the ITC issued Notices of Investigation in Certain Toner Supply Containers and Components Thereof (I) (Inv. No. 337-TA-1259)

The Patent Trial and Appeals Board (PTAB) recently overruled an examiner's finding of obviousness of claims premised on a "missing" moisture permeability feature in a composition designed for moisture absorption.

In contrast, the POP noted that it does not generally expect fairness and prejudice concerns to be implicated by, for example, the mistake or omissions of a petitioner.

On April 22, 2022, the USPTO issued a press release and announced that it is increasing transparency as it works to formalize the Director review process by way of providing updates...

The Trademark Trial and Appeal Board affirmed the refusal of LEGION OF GOOD WILL for charitable services in light of several of Goodwill Industries' prior registered GOODWILL Marks.

The key challenge faced by the UPSTO in generating their findings was to determine whether a particular patent document is directed to AI.

An ongoing discussion in the field of artificial intelligence (AI) and patent law relates to the implications of AI toward the standard for a person having ordinary skill in the art ("PHOSITA").

On May 18, 2021 the ITC issued the public version of its opinion in Certain Collapsible and Portable Furniture (Inv. No. 337-TA-1178). According to the opinion, the Commission determined that there was...

The Board agreed with petitioner LG and denied patent owner Wi-Lan's motion to dismiss.

On October 11, the FDA announced the formation of a new Digital Health Advisory Committee to assist the FDA in exploring the complex, scientific and technical issues related to digital health technologies (DHTs).

In an interesting, but non-precedential, decision from the Court of Appeals for the Federal Circuit (Supernus Pharmaceuticals, Inc. v TWI Pharmaceuticals, Inc et al), the Court affirmed a decision from the U.S. District Court of New Jersey.

In Corcept Therapeutics, Inc. v. Teva Pharmaceuticals U.S.A., Inc., C.A. 18-03632, December 29, 2023, the Chief Judge Bumb of the New Jersey District Court...

On March 12, 2021, ALJ Clark Cheney issued the public version of Order No. 22 (dated January 7, 2021) denying Respondent Regeneron Pharmaceuticals' ("Regeneron")

On March 15, 2022, Chief ALJ Clark S. Cheney issued an initial determination ("ID") on violation of section 337 in Certain Toner Supply Containers and Components Thereof (I) (Inv. No. 337-TA-1259).

On April 23, 2021, ALJ Dee Lord issued the public version of Order No. 41 (dated April 2, 2021) finding a violation of section 337 in Certain Electronic Candle Products and Components Thereof...

On October 22, 2020, the ALJ issued an initial determination terminating the investigation based on a proposed consent order, which the Commission entered on November 12, 2020.

In the Federal Circuit decision in Amgen Inc. v. Sanofi, while invalidating two of Amgen's antibody patents, the CAFC made the following statement regarding the enablement requirement of 35 U.S.C. §112.

Appeal of Examiner's Final Rejection of claims 18-20 reversed by PTAB based on calculation of an effective human dosage from a "minimal risk of toxicity"...